CA125 is elevated in the serum of most women with ovarian cancer and is recommended as an ovarian cancer screening biomarker clinically in the U.S. For early detection of HCC, the most common serological test is for α-fetoprotein (AFP) (26–28). This evidence concerns the gene AFP and hepatocellular carcinoma.